Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

UK NICE rejects NHS use of ozanimod for MS treatment

pharmaceutical-technologyMay 17, 2021

Tag: ozanimod , NICE , MS , NHS

PharmaSources Customer Service